Clinical Trial

Impact and Influence of the Use of Hypnosis Adapted to People With Severe Stage Neurocognitive Disorder (HAPNeSS) on the Professional Practices of EHPAD (Establishment for Dependent Elderly People) Caregivers With Elderly Residents

Study acronym: HAPNeSS-E
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated August 2, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to propose a non-anxiety-inducing method of managing behavioral disorders for patients and healthcare professionals. The main objective of this study is to evaluate the implementation, use and effects of HAPNeSS (Hypnosis Adapted to People with Severe Neurocognitive Disorders) training on the management of residents aged over 75 with moderately severe to severe Alzheimer's disease or a related disorder, who may present behavioral disorders, with caregivers working in EHPAD.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06535763
Lead Sponsor University Hospital, Bordeaux
Conditions Alzheimer Disease, Behavior Disorders
Enrollment 36 participants
Start Date 2024-09
Primary Completion 2025-03 (estimated)
Study Completion 2025-03 (estimated)
Updated on ClinicalTrials.gov 2024-08-02